GSK — GSK plc
Median target
$67.1
calls from the last 12 months
Implied return
+37.8%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
2/2/20 net
Buy / Hold / Sell
Which analysts are behind GSK's consensus?
See every current rating, price target and the analysts' track records for GSK plc — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 6 analysts with calls on GSK updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
GSK elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: #10 in Gaining attention (3.1× vs usual)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2025-10-30 | Congress | Lisa McClainMI-MI09 | Sale | since trade +7.4%, vs market +4.2% | $1K–$15K |
| 2025-09-23 | Congress | Valerie HoyleOR-OR04 | Sale | since trade +24.4%, vs market -10.1% | $1K–$15K |
| 2024-11-25 | Congress | Marjorie Taylor Mrs GreeneGA-GA14 | Purchase | since trade +52.7%, vs market +24.2% | $1K–$15K |
| 2023-07-10 | Congress | Daniel GoldmanNY-NY10 | Sale | since trade +63.4%, vs market +14.3% | $15K–$50K |
| 2023-03-01 | Congress | Virginia FoxxNC-NC05 | Sale | since trade +63.0%, vs market +36.3% | $50K–$100K |
| 2022-08-09 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +43.8%, vs market -49.1% | $1K–$15K |
| 2022-08-05 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +41.9%, vs market -50.1% | $15K–$50K |
| 2022-07-12 | Congress | Virginia FoxxNC-NC05 | Sale | since trade +38.9%, vs market +69.5% | $100K–$250K |
| 2022-07-06 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +33.6%, vs market -73.6% | $1K–$15K |
| 2022-04-08 | Congress | Virginia FoxxNC-NC05 | Purchase | since trade +24.4%, vs market -53.7% | $1K–$15K |
More: congressional trades on GSK · insider activity · executive branch · trending